AU2003273051A1 - Solidified preparation aiming at promoting drug absorption - Google Patents

Solidified preparation aiming at promoting drug absorption

Info

Publication number
AU2003273051A1
AU2003273051A1 AU2003273051A AU2003273051A AU2003273051A1 AU 2003273051 A1 AU2003273051 A1 AU 2003273051A1 AU 2003273051 A AU2003273051 A AU 2003273051A AU 2003273051 A AU2003273051 A AU 2003273051A AU 2003273051 A1 AU2003273051 A1 AU 2003273051A1
Authority
AU
Australia
Prior art keywords
drug absorption
promoting drug
solidified preparation
preparation aiming
aiming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273051A
Inventor
Kanji Takada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioserentach Co Ltd
Original Assignee
Bioserentach Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioserentach Co Ltd filed Critical Bioserentach Co Ltd
Publication of AU2003273051A1 publication Critical patent/AU2003273051A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003273051A 2002-11-15 2003-10-20 Solidified preparation aiming at promoting drug absorption Abandoned AU2003273051A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002331549A JP2006056781A (en) 2002-11-15 2002-11-15 Solidified preparation containing surfactant
JP2002-331549 2002-11-15
PCT/JP2003/013367 WO2004045586A1 (en) 2002-11-15 2003-10-20 Solidified preparation aiming at promoting drug absorption

Publications (1)

Publication Number Publication Date
AU2003273051A1 true AU2003273051A1 (en) 2004-06-15

Family

ID=32321634

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273051A Abandoned AU2003273051A1 (en) 2002-11-15 2003-10-20 Solidified preparation aiming at promoting drug absorption

Country Status (3)

Country Link
JP (1) JP2006056781A (en)
AU (1) AU2003273051A1 (en)
WO (1) WO2004045586A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873923B1 (en) * 2004-08-05 2007-01-12 Gattefosse Holding Sa ANHYDROUS SOLID PARTICLE CONTAINING A LIQUID LIPIDIC COMPOSITION AND PHARMACEUTICAL COMPOSITION CONTAINING SAID PARTICLES
AR045841A1 (en) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie A SOLID PHARMACEUTICAL COMPOSITION THAT INCLUDES THE TIAZOLIL METHYL ESTER OF THE ACID [5S- (5R *, 8R *, 10R *, 11R *)] -10- HYDROXY-2-METHYL-5- (1-METHYTILE) -1- [2 - (1-METHYLE) -4-TIAZOLIL] -3,6-DIOXO-8,11-BIS (PHENYLMETIL) -2,4,7,12- TETRAAZATRIDECAN-13-OICO AND A PROCEDURE TO PREPARE IT.
EP1855655A2 (en) * 2005-02-25 2007-11-21 F. Hoffmann-Roche AG Tablets with improved drug substance dispersibility
WO2009044854A1 (en) * 2007-10-03 2009-04-09 Asahi Breweries, Ltd. Granule, tablet, and their production methods
US20090111736A1 (en) * 2007-10-29 2009-04-30 Sri International Orally-Absorbed Solid Dose Formulation for Vancomycin
JP2010189337A (en) * 2009-02-19 2010-09-02 Asahi Breweries Ltd Granule and tablet containing poorly soluble substance, and method for solubilizing poorly soluble substance
JP6344678B2 (en) * 2013-09-27 2018-06-20 キョーリンリメディオ株式会社 Telmisartan-containing preparation and method for producing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
JPS58213073A (en) * 1982-06-07 1983-12-10 Masatoshi Yamada Solidification of oily substance
EP0448091B1 (en) * 1990-03-23 1998-08-05 The Green Cross Corporation Pharmaceutical composition containing slightly water-soluble drug
JP3037393B2 (en) * 1990-10-22 2000-04-24 大正薬品工業株式会社 Method for producing solid drug for oral administration
JPH0616537A (en) * 1992-06-30 1994-01-25 Green Cross Corp:The Medicinal composition of sparingly water soluble drug
JP3565975B2 (en) * 1996-02-08 2004-09-15 株式会社ノエビア External preparation for skin
JPH1017495A (en) * 1996-06-26 1998-01-20 Green Cross Corp:The Medicinal composition of hardly water-soluble medicine
GB9808581D0 (en) * 1998-04-22 1998-06-24 Nycomed Imaging As Improvements in or relating to contrast agents
US20010025046A1 (en) * 1999-06-24 2001-09-27 Rong(Ron) Liu Self-emulsifying systems containing anticancer medicament
JP2000016934A (en) * 1998-06-30 2000-01-18 Eisai Co Ltd Tablets including teprenone
US6562372B1 (en) * 1998-11-06 2003-05-13 Fuji Chemical Industry Co., Ltd. Tocotrienol-containing powder, a process for preparing it and a tablet comprising compressed said powder into a tablet form
KR100342943B1 (en) * 1999-08-04 2002-07-02 민경윤 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration comprising same
US6793934B1 (en) * 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
JP2001316248A (en) * 2000-02-28 2001-11-13 Eisai Co Ltd Method of producing oily medicine containing composition
CA2412776C (en) * 2000-06-16 2011-03-15 Mitsubishi Pharma Corporation Compositions controlling release ph range and/or speed

Also Published As

Publication number Publication date
JP2006056781A (en) 2006-03-02
WO2004045586A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003246810A1 (en) Diphenylpyridine derivatives, the preparation thereof, and pharmaceutical compositions containing said derivatives
AU2003291103A1 (en) Pharmaceutical composition
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
AU2002358700A1 (en) Urea derivatives as vr1- antagonists
IL172733A0 (en) Diphenylpyridine derivatives, preparation and therapeutic application thereof
AU2003901813A0 (en) Pharmaceutical derivatives
AU2003250372A1 (en) Pharmaceutical composition
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003279911A1 (en) Therapeutic formulations
AU2003244201A1 (en) Transdermal absorption preparation
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003268672A1 (en) Drug absorbability improving agents
AU2003255987A1 (en) Improvements relating to phase-lock loops
AU2003281182A1 (en) Composition for nasal absorption
AU2003215708A1 (en) Orodispersible pharmaceutical composition comprising perindopril
AU2003273051A1 (en) Solidified preparation aiming at promoting drug absorption
AU2003215150A1 (en) Therapeutic compounds
AU2002251448A1 (en) Oral absorbed drugs
GB0206505D0 (en) Pharmaceutical combination
AU2003284460A1 (en) Medicinal composition
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003280799A1 (en) Medicinal composition
PL373409A1 (en) Pharmaceutical combination
AU2003255954A1 (en) Substituted glycine derivatives for use as medicaments
AU2003264443A1 (en) Preparation for external use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase